Time to relapse in chronic lymphocytic leukemia and DNA-methylation-based biological age
Authors:
Open Access
- 10 May 2023
- journal article
- research article
- Published by Springer Nature in Clinical Epigenetics
- Vol. 15 (1) , 1-8
Abstract
Chronic lymphocytic leukemia (CLL) is a mature B cell neoplasm with a predilection for older individuals. While previous studies have identified epigenetic signatures associated with CLL, whether age-related DNA methylation changes modulate CLL relapse remains elusive. In this study, we examined the association between epigenetic age acceleration and time to CLL relapse in a publicly available dataset. DNA methylation profiling of 35 CLL patients prior to initiating chemoimmunotherapy was performed using the Infinium HumanMethylation450 BeadChip. Four epigenetic age acceleration metrics (intrinsic epigenetic age acceleration [IEAA], extrinsic epigenetic age acceleration [EEAA], PhenoAge acceleration [PhenoAA], and GrimAge acceleration [GrimAA]) were estimated from blood DNA methylation levels. Linear, quantile, and logistic regression and receiver operating characteristic curve analyses were conducted to assess the association between each epigenetic age metric and time to CLL relapse. EEAA (p = 0.011) and PhenoAA (p = 0.046) were negatively and GrimAA (p = 0.040) was positively associated with time to CLL relapse. Simultaneous assessment of EEAA and GrimAA in male patients distinguished patients who relapsed early from patients who relapsed later (p = 0.039). No associations were observed with IEAA. These findings suggest epigenetic age acceleration prior to chemoimmunotherapy initiation is associated with time to CLL relapse. Our results provide novel insight into the association between age-related DNA methylation changes and CLL relapse and may serve has biomarkers for treatment relapse, and potentially, treatment selection.Keywords
This publication has 40 references indexed in Scilit:
- DNA methylation age of human tissues and cell typesGenome Biology, 2013
- Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevanceFrontiers in Genetics, 2013
- Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemiaEpigenetics, 2012
- A decade of exploring the cancer epigenome — biological and translational implicationsNature Reviews Cancer, 2011
- Differential genome-wide array–based methylation profiles in prognostic subsets of chronic lymphocytic leukemiaBlood, 2010
- Improved survival in chronic lymphocytic leukemia in the past decade: a population-based study including 11,179 patients diagnosed between 1973-2003 in SwedenHaematologica, 2009
- Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997–2002Cancer Causes & Control, 2007
- Hepatic CYP2B6 Expression: Gender and Ethnic Differences and Relationship to CYP2B6 Genotype and CAR (Constitutive Androstane Receptor) ExpressionThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Quantile RegressionJournal of Economic Perspectives, 2001
- No Adjustments Are Needed for Multiple ComparisonsEpidemiology, 1990